title: Secondary hyperparathyroidism is not always an obstacle to improved growth during recombinant human growth hormone treatment.
authors.forename: S
authors.initials: S
authors.lastname: Picca
authors.forename: I
authors.initials: I
authors.lastname: Perruzza
authors.forename: M
authors.initials: M
authors.lastname: Cappa
authors.forename: G
authors.initials: G
authors.lastname: Rizzoni
mesh_terms: D000293:Adolescent; D002648:Child; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood / Q000188:drug therapy; D005260:Female; D006130:Growth Disorders / Q000097:blood / Q000188:drug therapy*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000503:physiopathology*; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis; D012189:Retrospective Studies
chemical_list: D010281:Parathyroid Hormone; D013006:Growth Hormone